May 17, 2019 / 03:00PM GMT
Operator
Good morning. My name is Latania, and I will be your conference operator today. At this time, I would like to welcome everyone to the Barclays Biopharma CEO/CFO Conference Call Series with Regeneron. (Operator Instructions)
I would now like to turn the call over to your host, Mr. Geoff Meacham. Sir, you may begin.
Geoffrey Christopher Meacham - Barclays Bank PLC, Research Division - MD & Senior Research Analyst
Okay. Great. Thanks, Latania, and thanks, everyone, for joining us. I'm Geoff Meacham. I'm the senior biopharma analyst here at Barclays. My team is on the phone as well. We have Greg, Scott, [Olivia] and Jason, and we're thrilled to have Regeneron as part of our CEO/CFO call series. And we have a big crew today. We have Marion McCourt who's Senior Vice President, Head of Commercial. We have Bob Landry who's Executive Vice President and CFO. And then we have Jay Markowitz as well who is Senior Vice President, Portfolio Management. So welcome, guys.
Robert E. Landry - Regeneron Pharmaceuticals, Inc. - Executive VP
Regeneron Pharmaceuticals Inc at Barclays Biopharmaceuticals CEO/CFO Conference Call Series Transcript
May 17, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers